The European Commission approved the drug, an oral solution containing highly purified plant-derived cannabidiol, for use in adjunctive therapy of seizures associated with Lennox-Gastaut syndrome ...

Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical ...

The Company's lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.

Medical marijuana consists primarily of chemical compounds called cannabinoids, including tetrahydrocannabinol (THC), cannabidiol (CBD), and others like terpenes. The THC cannabinoid is the ...

Cannabidiol may reduce scan-related anxiety among women with advanced breast cancer, according to results of randomized phase ...

Detailed price information for Cardiol Therapeutics (CRDL-Q) from The Globe and Mail including charting and trades.